Outset Medical's Upcoming Financial Results Announcement
Outset Medical, Inc. (NASDAQ: OM) is set to unveil its financial results for the third quarter of 2024. This announcement is a key event for the company, which is recognized for its innovative approach in the medical technology sector, particularly in dialysis technology. Outset has been at the forefront of reducing the complexities and costs associated with dialysis, aiming to enhance the patient experience and operational efficiencies.
When and How to Join the Conference Call
The financial results will be released after the market closes on a Wednesday. On the same day, the executive team, including Leslie Trigg, the Chair and CEO, and Nabeel Ahmed, the CFO, will lead a conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). This call aims to discuss the company’s financial and operational outcomes for the quarter.
Participating in the Conference Call
Listeners who wish to join the conference call can register online. By doing this, they will receive pertinent dial-in numbers and a unique PIN needed to participate. Outset encourages participants to register early, ideally more than 15 minutes before the call begins. Additionally, a live audio webcast of the event will be accessible on the company's investor relations website.
Innovative Technology by Outset Medical
Outset Medical is renowned for its pioneering work in dialysis through its flagship product, the Tablo® Hemodialysis System. This system has been a game-changer in dialysis treatment. It has received FDA clearance for use not just in hospitals but also for home treatments, thus broadening patient access to essential care.
How Tablo Revolutionizes Dialysis
The Tablo system integrates several functions that streamline the dialysis process. It combines water purification and on-demand dialysate production into a cohesive unit. This remarkable feature effectively allows the Tablo to act like a dialysis clinic on wheels. With 2-way wireless data transmission and a sophisticated data analytics platform, providers can deliver care seamlessly, anytime and anywhere.
About Outset Medical, Inc.
Founded with the vision to simplify dialysis, Outset Medical aims to transform the experience for patients and healthcare providers alike. The technology behind Tablo represents a significant leap forward, making it possible for people to receive treatment outside of conventional settings, thus enhancing convenience and comfort.
Contact Information for Investor Relations
For those seeking more information or having inquiries regarding Outset Medical, Jim Mazzola leads the Investor Relations. Interested parties can reach him via email, which remains the best channel for direct communication.
Frequently Asked Questions
What is the purpose of the upcoming conference call?
The conference call aims to discuss Outset Medical's financial results and operational updates for the third quarter of 2024.
When will the financial results be released?
The financial results will be released after the close of trading on a Wednesday, with the conference call scheduled for the same day.
How can I participate in the conference call?
To participate, interested individuals need to register online to receive dial-in details and a PIN number for access to the call.
What is the Tablo Hemodialysis System?
Tablo is a groundbreaking hemodialysis system designed to simplify dialysis treatment, enabling use from hospitals to patients' homes.
Who can I contact for more information about Outset Medical?
For inquiries, you can contact Jim Mazzola, who manages Investor Relations and is available via email.
